TP53 and neoplasm: In two similar trials, immunization against a mixture of TRP2:180–188 and modified p53:232–240 in VM resulted in tumor rejection in 60–80% of treated mice within 26–32 days post-immunization, (data not shown) and these mice remained tumor-free at the end of the trial (day 40 post-immunization).